These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 302538)

  • 1. [Two-phase course of IgM and rheumatoid factors during D-penicillamine therapy].
    Stojan B; Hasler F
    Z Rheumatol; 1977; 36(5-6):194-9. PubMed ID: 302538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
    Schmidt KL; Ott VR
    Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG-, IgM- and IgA-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluorescence method.
    Kallerup HE; Egeskjold EM; Graudal H
    Scand J Rheumatol; 1979; 8(1):1-9. PubMed ID: 373087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheumatoid factors of immunoglobulin classes IgA, IgG and IgM: methods of determination and clinical value].
    Hermann E; Vogt P; Müller W
    Schweiz Med Wochenschr; 1986 Sep; 116(38):1290-7. PubMed ID: 3775335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
    Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Presence of cryoprecipitates in the serum of patients with rheumatoid arthritis].
    Massias P; Segond P; Bisson M; Grangeot L; Boucheteil P; Francoual J; Capel F; Pillot J
    Rev Rhum Mal Osteoartic; 1975; 42(7-9):489-96. PubMed ID: 1080877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
    Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum immunoglobulin patterns in rheumatoid arthritis].
    Dreher R
    Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factors and HLA-DR4 in RA.
    Emery P; Panayi GS; Welsh KI; Cole BC
    J Rheumatol; 1985 Apr; 12(2):217-22. PubMed ID: 3875716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective study of the effects of D-penicillamine and pyrithioxin in the treatment of rheumatoid arthritis].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):281-7. PubMed ID: 6879095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis with vasculitis.
    Veys EM; Gabriel PA; Coigne E; Mielants H
    Scand J Rheumatol; 1976; 5(1):1-6. PubMed ID: 1257704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating protein complexes in D-penicillamine therapy of rheumatoid arthritis. Correlation between IgG- and alpha 1-antitrypsin-IgA complexes and clinical response.
    Norberg R; Wollheim FA; Gedda PO
    Acta Med Scand; 1980; 208(5):393-6. PubMed ID: 6969974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.